Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$8.7M
1 round on record
Latest round
$8.7M
Venture round · Mar 2024 · 2 yr ago
Team
11-50
employees, estimated range
Hiring now
1
open roles
The money's age
Long since its last round
31 months since the last round · hiring slowed
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 5, 2024 Raised a round Venture round $8.7M
Funding rounds
RoundDateAmountInvestorsSource
Venture round Mar 2024 $8.7M — sifted.eu
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
The growth of Revatis is supported by its innovative and patented technology to obtain multipotent adult mesenchymal stem cells from a…
Syntax BioSeries A · 4 mo ago • 51-200 employees
Syntax Bio is a synthetic biology company programming the next generation of stem cell-derived therapies and organoids.
QkineVenture round · 3 mo ago • Founded 2016 • 11-50 employees
High purity, bioactive recombinant cytokine proteins and growth factors made for stem cell, organoid and regenerative medicine.
CellinoFounded 2017
Cellino is a Massachusetts biotechnology company founded in 2017. It automates stem cell manufacturing with laser editing, imaging and…
Tavra BiosciencesVenture round $300k · 6 mo ago • Founded 2026 • 11-50 employees
Explore stem cells and regenerative medicine. Learn about mCELL™, published research, and resources for patients and physicians.
AnteAGE® is a stem cell science research & development company dedicated to delivering advanced growth factor skincare products &…

Overview

Cellcolabs produces GMP mesenchymal stem cells (MSCs) for clinical research and collaboration with clinics and scientists worldwide.

News

News Dagens industri 9 months ago
Cellcolabs vd avgår med omedelbar verkan
Stamcellsbolaget Cellcolabs, känt för att backas av flera tunga techprofiler och för sina kliniska studier på en avlägsen paradisö. Nu byter man hastigt…
Read more
Report
Podcast Spotify 10 months ago
Spotify - Web Player Read more
Report
News breakit.se 12 months ago
Injicerar techprofiler med stamceller - nära miljardvärdering:
Svenska Cellcolabs vill demokratisera användningen av stamcellsterapi - och har tidigare gjort kliniska försök med techmiljardären Bryan Johnson.Nu fyller bolaget på kassan med 113 miljoner kronor - och når nästan miljardvärdering.
Read more
Report
News Dagens industri 12 months ago
Säljer stamceller till kändisar - fyller kassan med 110 Mkr
Det svenska bioteknikbolaget Cellcolabs, som utvecklar industriell produktion av stamceller, har redan idrottare och kändisar som
Read more
Report
News TNW Deep-tech 1 year ago
Stem cell startup proclaims 'inflection point' for medicine as mass production nears
Swedish biotech Cellcolabs stem cell therapies are approaching commercial scale - a landmark poised to transform medicine.
Read more
Report
Show more news

Growth

Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~5 hours
Today
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Administrative
100% ▲

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
1
Countries
2
Busiest office
Bangkok
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Bangkok Thailand
1 open roles 1 posted in 90 days 10-50 est. staff
hires for Administrative
seen since Sep 2026 job postings
Solna Sweden
Regional office
Scheeles väg 3, Solna, 171 65, SE
company site

Financials

Total raised
$8.7M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $8.7M Details